P70.01 Distribution of CCND1 Mutations in East Asian Patients With Non-Small Cell Lung Cancer

H. Feng,C. Xu,W. Wang,D. Wang,Y. Zhu,W. Zhuang,M. Fang,T. Lv,Yinglin Song
DOI: https://doi.org/10.1016/j.jtho.2021.01.1012
IF: 20.121
2021-01-01
Journal of Thoracic Oncology
Abstract:CCND1 is a member of the cyclin D family and promotes G1-S transition in cell proliferation. In the TransATAC substudy, breast cancers with CCND1 amplification were found to have a poor prognosis. In addition, overexpression of CCND1 demonstrates resistance to chemotherapy in vitro. The aim of this study is to investigate mutations and prognosis of non-small-cell lung cancer (NSCLC) harboring CCND1 mutations.
What problem does this paper attempt to address?